Facebook tracking pixel
F30.9
ICD-10-CM
Mania

Understanding mania diagnosis? Find information on manic episode symptoms, bipolar disorder, and related mental health conditions. Explore clinical documentation guidelines, ICD-10 CM codes (F30.1, F30.2, F30.8, F30.9), DSM-5 criteria, and best practices for healthcare professionals. Learn about differential diagnosis, assessment tools, and treatment options for mania and hypomania. This resource offers valuable insights into accurate medical coding and comprehensive patient care related to manic episodes and bipolar I disorder.

Also known as

Manic Episode
Bipolar Mania

Diagnosis Snapshot

Key Facts
  • Definition : A mood state of abnormally elevated energy, euphoria, and irritability.
  • Clinical Signs : Racing thoughts, impulsivity, decreased sleep, grandiosity, rapid speech.
  • Common Settings : Psychiatric hospitals, outpatient clinics, community mental health centers.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC F30.9 Coding
F30-F39

Mood [affective] disorders

Covers various mood disorders including mania, bipolar, and depression.

F31

Bipolar affective disorder

Includes manic episodes, often alternating with depressive episodes.

F30

Manic episode

Specifically describes a distinct period of abnormally elevated mood and activity.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the mania with psychotic features?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Elevated mood, increased energy.
Hypomania, less severe than mania.
Mixed features of mania/depression.

Documentation Best Practices

Documentation Checklist
  • Manic episode duration documented (DSM-5 criteria)
  • Distinct period of abnormally elevated mood
  • Increased energy or activity documented
  • At least three manic symptoms clearly listed
  • Impairment in social/occupational functioning noted

Coding and Audit Risks

Common Risks
  • Unspecified Mania Coding

    Coding mania without specifying episode type (e.g., single, recurrent, current) leads to inaccurate severity reflection and reimbursement.

  • Comorbidity Overlooked

    Failing to code co-existing conditions like anxiety or substance use with mania impacts risk adjustment and care planning.

  • Medical Necessity Documentation

    Insufficient documentation supporting the medical necessity of services provided for mania can trigger audit denials.

Mitigation Tips

Best Practices
  • Accurate ICD-10-CM coding (F30.x) for bipolar mania documentation.
  • Thorough clinical notes: episode duration, symptom severity, impairment.
  • Differential diagnosis: rule out substance-induced mania, other medical causes.
  • Medication reconciliation: document prescribed mood stabilizers, antipsychotics.
  • Monitor patient adherence, document treatment response for compliance reviews.

Clinical Decision Support

Checklist
  • Elevated mood ICD-10 F30, DSM-5 296.xx: Document distinct period.
  • Increased energy or activity: Duration and specific examples.
  • Inflated self-esteem or grandiosity: Patient reported examples.
  • Decreased need for sleep: Document baseline sleep and change.
  • Talkativeness or pressured speech: Note observations and impact.

Reimbursement and Quality Metrics

Impact Summary
  • Mania Diagnosis Reimbursement: Accurate ICD-10-CM coding (F30.x) crucial for maximizing reimbursement. Coding specificity impacts payment and claim denials.
  • Quality Metrics Impact: Mania readmission rates affect hospital quality reporting and value-based payments. Timely diagnosis and treatment are key.
  • Coding Accuracy: Precise documentation of manic episode severity (e.g., mild, moderate, severe) ensures appropriate DRG assignment and reimbursement.
  • Hospital Reporting: Proper coding and documentation of mania support accurate public health data reporting and resource allocation.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: How can I differentiate between mania with psychotic features and schizophrenia in a differential diagnosis, considering both present similar symptoms like delusions and hallucinations?

A: Differentiating between mania with psychotic features and schizophrenia can be challenging due to overlapping symptoms like delusions and hallucinations. However, key distinctions exist. In mania, the psychotic features are typically mood-congruent, meaning they align with the elevated or irritable mood. For example, a person experiencing manic grandiosity might believe they have superpowers. In schizophrenia, delusions and hallucinations are often mood-incongruent and more bizarre in nature. Additionally, consider the temporal relationship between mood disturbance and psychosis. In mania, the mood disturbance typically precedes the psychotic features, while in schizophrenia, psychosis is the primary feature with mood disturbances being secondary if present. Furthermore, observe the overall clinical picture. Manic episodes tend to have a more acute onset and are characterized by other symptoms like increased energy, decreased need for sleep, and pressured speech. Schizophrenia presents with a broader range of negative symptoms like flat affect, avolition, and social withdrawal. Explore how a thorough patient history, including family history of mood disorders and psychotic illnesses, can aid in accurate diagnosis. Consider implementing standardized assessment tools like the Young Mania Rating Scale (YMRS) and the Positive and Negative Syndrome Scale (PANSS) to further support your clinical judgment.

Q: What are the most effective evidence-based pharmacological treatment strategies for acute mania in bipolar I disorder, specifically addressing the use of mood stabilizers, antipsychotics, and benzodiazepines?

A: Evidence-based pharmacological treatment of acute mania in bipolar I disorder typically involves a combination of mood stabilizers, antipsychotics, and sometimes benzodiazepines. Lithium, valproate, and carbamazepine are considered first-line mood stabilizers for long-term management and can be helpful in acute episodes. Second-generation antipsychotics, such as risperidone, olanzapine, quetiapine, and aripiprazole, have demonstrated efficacy in managing acute manic symptoms, including psychosis and agitation. Benzodiazepines like lorazepam or clonazepam can be used adjunctively for short-term control of severe agitation, insomnia, and anxiety associated with mania, but their use should be carefully monitored due to the risk of dependence. The choice of specific medication depends on factors like patient-specific characteristics, comorbid conditions, and prior treatment response. Learn more about the comparative efficacy and side effect profiles of different antipsychotic medications in the context of acute mania to tailor treatment effectively. Consider implementing a careful titration strategy to minimize adverse effects and optimize therapeutic response.

Quick Tips

Practical Coding Tips
  • Document manic episode specifics
  • Code F30.x for Mania NOS
  • Specify duration, severity
  • Consider F31.x if bipolar
  • Rule out substance/medical cause

Documentation Templates

Patient presents with symptoms consistent with a manic episode, fulfilling DSM-5 criteria for a diagnosis of Mania.  The patient exhibits elevated, expansive, or irritable mood, along with increased energy and activity levels, persisting for at least one week and present most of the day, nearly every day.  Symptoms include inflated self-esteem or grandiosity, decreased need for sleep, pressured speech, racing thoughts or flight of ideas, distractibility, increased goal-directed activity or psychomotor agitation, and excessive involvement in activities that have a high potential for painful consequences (e.g., unrestrained buying sprees, sexual indiscretions, foolish business investments).  These manic symptoms cause significant functional impairment in social or occupational settings, necessitate hospitalization to prevent harm to self or others, or include psychotic features.  The episode is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a medication, other treatment) or another medical condition (e.g., hyperthyroidism).  Differential diagnoses considered include bipolar disorder, substance-induced manic episode, and medical conditions mimicking mania.  Assessment includes a thorough review of psychiatric history, family history of mood disorders, substance use history, current medication list, and physical examination.  Mental status examination reveals rapid speech, tangential thinking, and labile affect.  Laboratory tests are ordered to rule out any underlying medical conditions contributing to the presentation.  Initial treatment plan includes mood stabilizers (e.g., lithium, valproate), antipsychotics (e.g., risperidone, quetiapine), and close monitoring for medication efficacy and side effects.  Patient education focuses on medication adherence, early warning signs of relapse, and lifestyle modifications to promote mood stability.  Referral to a psychiatrist or mental health specialist is recommended for ongoing management of bipolar disorder.  Prognosis depends on individual factors, including treatment adherence and the presence of comorbid conditions.  Follow-up appointments are scheduled to monitor symptom progression, medication response, and overall functional status.  ICD-10 code F30.2 applies to this episode of Mania with psychotic features.  CPT codes for evaluation and management services will be determined based on the complexity of the patient encounter.